Mast Cell Activation Syndrome: Quantification of Mast Cells Across Conditions Reveals Limited Diagnostic Utility of Mast Cell Counts and Tryptase Depletion Index

Key Points

• This research investigates the effectiveness of mast cell counts and tryptase depletion index in diagnosing Mast Cell Activation Syndrome.
• Assessment of mast cell counts in multiple conditions
• Evaluation of diagnostic markers like CD25/CD30 and KIT mutations
• Analysis of tryptase depletion index across different health conditions
• Mast cell counts showed limited usefulness in diagnosis
• Alternative markers such as CD25/CD30 and KIT mutations were more relevant.
• Tryptase depletion index provided insufficient diagnostic information.

Abstract